ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,070.55
1.20%
US Tech 100
17,098.80
0.56%
Dow Jones
38,503.69
0.69%
Brent Oil
87.025
-0.62%
Bitcoin
66,406.19
-0.01%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
Symbol: 
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
04/24/20247:06AMAlliance NewsAlliance NewsTOP NEWS: AT&T profit down but confident as hails "record-low" churnLSE:0QZ1At&t Inc.
04/24/20247:05AMAlliance NewsAlliance NewsConcurrent awarded USD1.8 million contract from US defence companyLSE:CNCConcurrent Technologies Plc
04/24/20247:05AMPR Newswire (Canada)METRO Inc. to launch Moi Rewards in Ontario offering new ways to save
04/24/20247:05AMGlobeNewswire Inc.Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for the treatment of IgA NephropathyCSL.AX
04/24/20247:05AMPR Newswire (US)Silicon Labs Reports First Quarter 2024 ResultsNASDAQ:SLABSilicon Labs
04/24/20247:05AMPR Newswire (Canada)METRO inc. lance Moi en Ontario offrant de nouvelles façons d'économiser
04/24/20247:05AMGlobeNewswire Inc.Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for the treatment of IgA NephropathyNASDAQ:TVTXTravere Therapeutics Inc
04/24/20247:05AMPR Newswire (US)REGENXBIO to Participate in Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing SummitNASDAQ:RGNXREGENXBIO Inc
04/24/20247:04AMAlliance NewsAlliance NewsHeathrow ups passenger growth outlook after record start to 2024
04/24/20247:04AMPR Newswire (US)QSAN Unveils Latest Solutions for AI Era at COMPUTEX 2024
04/24/20247:03AMPR Newswire (US)Coast survey finds construction companies have significant gaps in their field expense management practices
04/24/20247:03AMPR Newswire (US)Too Much Acid in Your Diet: It's Probably Your Coffee
04/24/20247:03AMPR Newswire (US)Taylor Morrison Opens One of The Final New Build Communities in the Arvada MarketNYSE:TMHCTaylor Morrison Home Holding Company
04/24/20247:02AMAlliance NewsAlliance NewsEXTRA: Warpaint boosts annual earnings as consumers stick by cosmeticsLSE:W7LWarpaint London Plc
04/24/20247:01AMPR Newswire (US)Travelzoo Reports First Quarter 2024 ResultsNASDAQ:TZOOTravelzoo
04/24/20247:01AMGlobeNewswire Inc.HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated CancersNASDAQ:HOOKHOOKIPA Pharma Inc
04/24/20247:00AMGlobeNewswire Inc.Rogers Communications Reports First Quarter 2024 ResultsRCI-B
04/24/20247:00AMGlobeNewswire Inc.Rogers Communications Reports First Quarter 2024 ResultsNYSE:RCIRogers Communications Inc
04/24/20247:00AMGlobeNewswire Inc.Rogers Communications Reports First Quarter 2024 ResultsRCI-A
04/24/20247:00AMGlobeNewswire Inc.Shenandoah Telecommunications Company to Hold its First Quarter 2024 Earnings Call at 8:30 a.m. on Friday, May 3, 2024NASDAQ:SHENShenandoah Telecommunications Company
04/24/20247:00AMGlobeNewswire Inc.Smart Share Global Limited Files Its Annual Report on Form 20-FNASDAQ:EMSmart Share Global Limited
04/24/20247:00AMGlobeNewswire Inc.atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant DepressionNASDAQ:ATAIATAI Life Sciences NV
04/24/20247:00AMGlobeNewswire Inc.Alts Marketplace Unveils Latest Developments in Alternative Investments
04/24/20247:00AMGlobeNewswire Inc.Rogers Communications Declares 50 Cents per Share Quarterly DividendNYSE:RCIRogers Communications Inc
04/24/20247:00AMGlobeNewswire Inc.Rogers Communications Declares 50 Cents per Share Quarterly DividendRCI-A
04/24/20247:00AMGlobeNewswire Inc.Rogers Communications Declares 50 Cents per Share Quarterly DividendRCI-B
04/24/20247:00AMBusiness WireAirspeed Launches Culture Graph to Help Companies Measure the Cultural Health of Their Organization
04/24/20247:00AMGlobeNewswire Inc.Media Advisory: Day of Mourning 2024 - CLC Secretary-Treasurer Lily Chang to attend Saint John event
04/24/20247:00AMGlobeNewswire Inc.Satellite Applications Catapult trials Arqit Network Secure™NASDAQ:ARQQWArqit Quantum Inc
04/24/20247:00AMGlobeNewswire Inc.Crosschq Launches Insights, First-of-its-Kind Recruiting Analytics and Quality of Hire Engine

Your Recent History

USOTC
ASKH
Astika (PK)
NASDAQ
TSLA
Tesla
USOTC
BLLB
Bell Buckle (PK)
USOTC
PSRU
Valiant Eagle (PK)
USOTC
VPLM
Voip Pal Com (QB)
NASDAQ
AGBA
AGBA
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
NASDAQ
HOLO
MicroCloud Hologram
USOTC
DRNK
NoHo (PK)
USOTC
UBQU
Ubiquitech Software (PK)
USOTC
NLST
Netlist (QB)
USOTC
MGON
Megola (PK)
USOTC
MONI
Moon Equity (PK)
USOTC
BCAP
Baron Capital Enterprise (CE)
NASDAQ
COOP
Mr Cooper
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved